A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
Condition(s):RLSLast Updated:April 12, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):RLSLast Updated:April 12, 2021Withdrawn
Condition(s):Alcohol DependenceLast Updated:April 24, 2019Completed
Condition(s):SleepLast Updated:July 13, 2016Terminated
Condition(s):PainLast Updated:August 8, 2019Completed
Condition(s):Peripheral Nerve Disorder Associated With Repair of HerniaLast Updated:April 11, 2016Unknown status
Condition(s):PainLast Updated:October 13, 2014Completed
Condition(s):RLSLast Updated:June 9, 2021Recruiting
Condition(s):Benzodiazepine Dependence; Opioid DependenceLast Updated:April 24, 2019Completed
Condition(s):Chronic Pain Due to Trauma; Spinal Cord InjuriesLast Updated:March 7, 2019Withdrawn
Condition(s):Other Abortion; Spontaneous AbortionLast Updated:July 2, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.